Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Shock | 3 | 2017 | 1868 | 1.18 | Why? |
| Hemodynamics | 5 | 2018 | 1562 | 1.01 | Why? |
| Fluid Therapy | 3 | 2018 | 628 | 0.76 | Why? |
| Work Engagement | 1 | 2020 | 154 | 0.73 | Why? |
| Hypovolemia | 1 | 2018 | 65 | 0.69 | Why? |
| Life Support Care | 1 | 2018 | 161 | 0.67 | Why? |
| Hemodynamic Monitoring | 1 | 2017 | 61 | 0.65 | Why? |
| Cardiac Output | 1 | 2017 | 183 | 0.63 | Why? |
| Feedback | 1 | 2017 | 317 | 0.59 | Why? |
| Physical Examination | 2 | 2017 | 755 | 0.55 | Why? |
| Complement Activation | 1 | 2020 | 949 | 0.52 | Why? |
| Survivors | 3 | 2021 | 2619 | 0.49 | Why? |
| Critical Care | 9 | 2020 | 14081 | 0.46 | Why? |
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 1047 | 0.45 | Why? |
| Extracellular Traps | 1 | 2020 | 1036 | 0.45 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.41 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.35 | Why? |
| Sepsis | 3 | 2018 | 3517 | 0.34 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.34 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.33 | Why? |
| Critical Illness | 8 | 2020 | 17281 | 0.33 | Why? |
| ST Elevation Myocardial Infarction | 6 | 2019 | 3051 | 0.32 | Why? |
| Netherlands | 9 | 2021 | 3533 | 0.32 | Why? |
| Ventricular Function, Left | 4 | 2017 | 1555 | 0.32 | Why? |
| Resilience, Psychological | 1 | 2020 | 2329 | 0.30 | Why? |
| Metformin | 4 | 2019 | 640 | 0.30 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2018 | 1876 | 0.28 | Why? |
| Burnout, Professional | 1 | 2020 | 2489 | 0.28 | Why? |
| Patient Satisfaction | 1 | 2017 | 2517 | 0.27 | Why? |
| Ultrasonography | 2 | 2017 | 4409 | 0.27 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.26 | Why? |
| Organ Dysfunction Scores | 2 | 2020 | 1475 | 0.26 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.26 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.24 | Why? |
| Glucose | 2 | 2006 | 573 | 0.23 | Why? |
| Recovery of Function | 3 | 2021 | 2461 | 0.22 | Why? |
| Potassium | 1 | 2002 | 325 | 0.20 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 5002 | 0.20 | Why? |
| Simplified Acute Physiology Score | 1 | 2019 | 102 | 0.20 | Why? |
| Coronary Angiography | 3 | 2019 | 2275 | 0.20 | Why? |
| Insulin | 4 | 2011 | 1316 | 0.19 | Why? |
| Stroke Volume | 4 | 2017 | 2153 | 0.19 | Why? |
| Multimodal Imaging | 2 | 2020 | 534 | 0.19 | Why? |
| Peptic Ulcer | 1 | 2018 | 85 | 0.18 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.18 | Why? |
| Creatine Kinase, MB Form | 2 | 2017 | 259 | 0.18 | Why? |
| Myocardial Reperfusion | 2 | 2017 | 168 | 0.18 | Why? |
| Percutaneous Coronary Intervention | 4 | 2019 | 3646 | 0.17 | Why? |
| Norepinephrine | 1 | 2018 | 152 | 0.17 | Why? |
| Myocardium | 4 | 2017 | 2323 | 0.17 | Why? |
| Albumins | 1 | 2018 | 324 | 0.15 | Why? |
| Ventricular Remodeling | 2 | 2017 | 349 | 0.15 | Why? |
| Neurologic Examination | 1 | 2018 | 428 | 0.15 | Why? |
| Thyroidectomy | 1 | 2017 | 207 | 0.14 | Why? |
| Myocardial Infarction | 4 | 2018 | 3361 | 0.14 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.14 | Why? |
| Hypoglycemic Agents | 4 | 2017 | 2165 | 0.14 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.13 | Why? |
| Electrocardiography | 2 | 2019 | 3957 | 0.13 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.13 | Why? |
| Coronary Artery Bypass | 1 | 2019 | 629 | 0.12 | Why? |
| Natriuretic Peptide, Brain | 2 | 2017 | 1215 | 0.12 | Why? |
| Shock, Septic | 1 | 2002 | 1313 | 0.12 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2018 | 669 | 0.12 | Why? |
| Meta-Analysis as Topic | 1 | 2019 | 1289 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 2 | 2019 | 993 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2017 | 422 | 0.11 | Why? |
| Humans | 38 | 2021 | 930598 | 0.11 | Why? |
| Intensive Care Units | 8 | 2020 | 29594 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.10 | Why? |
| Peptide Fragments | 2 | 2017 | 2075 | 0.10 | Why? |
| Monitoring, Physiologic | 2 | 2018 | 1956 | 0.09 | Why? |
| Aged | 20 | 2021 | 215776 | 0.09 | Why? |
| Cardiotonic Agents | 1 | 2011 | 418 | 0.09 | Why? |
| Male | 24 | 2021 | 367725 | 0.09 | Why? |
| Female | 23 | 2021 | 380317 | 0.09 | Why? |
| Time Factors | 7 | 2021 | 31397 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Potassium Chloride | 1 | 2006 | 24 | 0.08 | Why? |
| Emergency Service, Hospital | 2 | 2021 | 14232 | 0.08 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.07 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.06 | Why? |
| Glucose Clamp Technique | 1 | 2002 | 39 | 0.06 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.06 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.06 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.06 | Why? |
| Magnetic Resonance Imaging, Cine | 2 | 2017 | 669 | 0.06 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
| Infusions, Intravenous | 2 | 2006 | 1224 | 0.06 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2006 | 365 | 0.06 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2019 | 5883 | 0.06 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Logistic Models | 3 | 2021 | 9089 | 0.05 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Students, Medical | 1 | 2020 | 4032 | 0.05 | Why? |
| Treatment Outcome | 5 | 2018 | 51732 | 0.05 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.05 | Why? |
| Linear Models | 2 | 2017 | 1914 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Length of Stay | 4 | 2021 | 11042 | 0.05 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.05 | Why? |
| Biomarkers | 6 | 2018 | 23361 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Mental Competency | 1 | 2020 | 128 | 0.05 | Why? |
| Selection Bias | 1 | 2019 | 201 | 0.05 | Why? |
| Blood Glucose | 3 | 2011 | 3642 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.04 | Why? |
| Administration, Ophthalmic | 1 | 2017 | 53 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2018 | 381 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Myocardial Reperfusion Injury | 1 | 2019 | 129 | 0.04 | Why? |
| Magnetic Resonance Angiography | 1 | 2019 | 282 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Preoperative Period | 1 | 2018 | 271 | 0.04 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Confidence Intervals | 1 | 2019 | 744 | 0.04 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.04 | Why? |
| Feasibility Studies | 2 | 2021 | 3467 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.04 | Why? |
| Burns | 1 | 2002 | 466 | 0.04 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Coronary Circulation | 1 | 2017 | 188 | 0.04 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.04 | Why? |
| Thyrotropin | 1 | 2017 | 262 | 0.04 | Why? |
| Lactic Acid | 1 | 2018 | 393 | 0.04 | Why? |
| Hyperglycemia | 1 | 2006 | 1363 | 0.04 | Why? |
| Phospholipids | 1 | 2017 | 202 | 0.04 | Why? |
| Data Interpretation, Statistical | 1 | 2019 | 657 | 0.04 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Triglycerides | 1 | 2017 | 478 | 0.03 | Why? |
| False Positive Reactions | 1 | 2019 | 1338 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.03 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.03 | Why? |
| Wounds and Injuries | 1 | 2006 | 1708 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.03 | Why? |
| Drug Combinations | 1 | 2002 | 3852 | 0.03 | Why? |
| False Negative Reactions | 1 | 2019 | 1785 | 0.03 | Why? |
| Point-of-Care Systems | 1 | 2006 | 2955 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Troponin | 1 | 2018 | 1058 | 0.03 | Why? |
| Troponin T | 1 | 2017 | 771 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.03 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.03 | Why? |
| Atrial Natriuretic Factor | 1 | 2011 | 75 | 0.03 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.03 | Why? |
| AMP-Activated Protein Kinases | 1 | 2011 | 93 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.03 | Why? |
| Glucose Tolerance Test | 1 | 2011 | 238 | 0.03 | Why? |
| Heart Ventricles | 1 | 2019 | 1139 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Adult | 5 | 2020 | 244371 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2002 | 3228 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.02 | Why? |
| Up-Regulation | 1 | 2016 | 2249 | 0.02 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2011 | 219 | 0.02 | Why? |
| Rats, Sprague-Dawley | 1 | 2011 | 987 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Phosphorylation | 1 | 2011 | 1060 | 0.02 | Why? |
| Fibrosis | 1 | 2011 | 800 | 0.02 | Why? |
| Education, Medical, Undergraduate | 1 | 2020 | 1392 | 0.02 | Why? |
| Energy Metabolism | 1 | 2011 | 451 | 0.02 | Why? |
| Risk | 1 | 2019 | 5288 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.02 | Why? |
| Injury Severity Score | 1 | 2006 | 287 | 0.02 | Why? |
| Echocardiography | 1 | 2019 | 3661 | 0.02 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.02 | Why? |
| Rats | 1 | 2011 | 2764 | 0.02 | Why? |
| Statistics as Topic | 1 | 2006 | 370 | 0.02 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.02 | Why? |
| Chemotherapy, Adjuvant | 1 | 2006 | 606 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2019 | 22971 | 0.02 | Why? |
| Cause of Death | 1 | 2016 | 4823 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2016 | 6551 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.01 | Why? |
| Alanine | 1 | 2017 | 5687 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Gene Expression Regulation | 1 | 2011 | 4020 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2011 | 10998 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Animals | 1 | 2011 | 78931 | 0.00 | Why? |
van der Horst's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(215)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_